In late 2019, an outbreak of coronavirus disease 2019 (COVID‐19) arose, caused by severe
acute respiratory syndrome coronavirus type 2 (SARS‐CoV‐2). This disease rapidly became …

Abstract SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the etiological
agent of COVID-19 (coronavirus disease 2019) and the cause of the current pandemic …

The SARS-CoV-2 spike protein has been shown to disrupt blood–brain barrier (BBB)
function, but its pathogenic mechanism of action is unknown. Whether angiotensin …

Air pollution can adversely affect the immune response and increase the severity of the viral
disease. The present study aimed to explore the relationship between symptomatology …

The occurrence of a novel coronavirus known as severe acute respiratory syndrome-
coronavirus-2 (SARS-CoV-2), created a serious challenge worldwide. SARS-CoV-2 has …

Abstract SARS–CoV-2 (COVID-19) infection can cause a severe respiratory distress
syndrome. The risk of severe manifestations and mortality characteristically increase in the …

Rice bran protein (RBP) is a plant protein obtained from rice bran, a byproduct produced
during rice milling process. It has been proved to be a high quality protein due to containing …

Cardiovascular disease is the major cause of mortality and disability, with hypertension
being the most prevalent risk factor. Excessive activation of the renin-angiotensin system …

Abstract The Coronavirus disease, 2019 (COVID-19) is caused by severe acute respiratory
syndrome Coronavirus 2 (SARS-CoV-2), which poses a major threat to human life and …

In the COVID-19 pandemic, drug repositioning has presented itself as an alternative to the
time-consuming process of generating new drugs. This review describes a drug repurposing …